Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Single-shot Adductor Canal Block Versus Continuous Femoral Nerve Block on Rehabilitation After Total Knee Replacement (AdORe - ACB)

NCT05487053 is registered in ClinicalTrials.gov with Negovsky Reanimatology Research Institute as lead sponsor.

NCT NCT05487053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05487053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Single-shot Adductor Canal Block Versus Continuous Femoral Nerve Block on Rehabilitation After Total Knee Replacement (AdORe - ACB)
Lead sponsor
Negovsky Reanimatology Research Institute
Phase
Not applicable
Overall status
Recruiting
Start date
February 3, 2024
Completion date
July 1, 2028
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gonarthrosis, osteo arthritis knee